{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:28:58Z","timestamp":1788557338756,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>In a recent study, using hydrogen cyanide as paradigm, we have shown that pharmacological knowledge evolves non-linearly (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38900251\/\" ext-link-type=\"uri\">https:\/\/pubmed.ncbi.nlm.nih.gov\/38900251\/<\/jats:ext-link>). The aim of this study was to investigate the changes in the presentation of the drugs pilocarpine and physostigmine in textbooks from 1878 to 2023. The categories of structure, molecular mechanism of action, pharmacokinetics, effects, indications, adverse drug reactions, interactions, and contraindications were evaluated. The pharmacological knowledge on the molecular mechanism, chemical structure, and pharmacokinetics of pilocarpine and physostigmine changed the most during the period of 150 years. Until 1944, textbooks did not mention a molecular mechanism of action of pilocarpine and from 1951 onwards they described the activation of muscarinic acetylcholine receptors as the molecular basis of pilocarpine\u2019s effect. Until 1944, most textbooks on physostigmine also did not mention the molecular mechanism of action. From 1951 onwards, the reversible inhibition of acetylcholinesterase is mentioned as the mechanism of action of physostigmine. In contrast, in the categories <jats:italic>effects<\/jats:italic>, <jats:italic>indications<\/jats:italic>, <jats:italic>adverse drug reactions<\/jats:italic>, <jats:italic>interactions<\/jats:italic>, and <jats:italic>contraindications<\/jats:italic>, the detected changes in the pharmacological knowledge presented were comparatively smaller. Older pharmacology textbooks were better than newer ones at discussing changes in knowledge and scientific errors. We noted substantial differences in the presentation of pilocarpine and physostigmine among German and US pharmacology textbooks. We show a decline of the clinical relevance of both drugs and their presentation in pharmacological textbooks with physostigmine being virtually irrelevant. But modern textbooks still discuss physostigmine substantially, fitting to studies on the obsolete drug reserpine (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38103060\/\" ext-link-type=\"uri\">https:\/\/pubmed.ncbi.nlm.nih.gov\/38103060\/<\/jats:ext-link>). Thus, textbooks often far lag clinical practice. Google Scholar conveys the incorrect impression that physostigmine is clinically more relevant than it is. An exponential decline in prescription numbers is a robust indicator of clinical obsolescence. From our study, we extract nine easily implementable take-home messages for future (pharmacology) textbook authors to ensure that this traditional teaching format will prevail against the competition of allegedly more \u201cmodern\u201d teaching media.<\/jats:p>","DOI":"10.1007\/s00210-024-03558-x","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T08:21:51Z","timestamp":1731399711000},"page":"5171-5193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The decline in the clinical relevance of pilocarpine and physostigmine monitored in pharmacology textbooks from 1878 to 2023: nine take-home messages for future (pharmacology) textbook authors"],"prefix":"10.1007","volume":"398","author":[{"given":"Laureen","family":"Ludwig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"3558_CR1","unstructured":"Aktories K, F\u00f6rtsermann U, Hofmann B, Starke K (eds) (2005) Allgemeine und spezielle Pharmakologie und Toxikologie: f\u00fcr Studenten der Medizin, Veterin\u00e4rmedizin, Pharmazie, Chemie und Biologie sowie f\u00fcr \u00c4rzte, Tier\u00e4rzte und Apotheker. 9, v\u00f6llig, \u00fcberarb. Elsevier, Urban & Fischer, M\u00fcnchen Jena"},{"key":"3558_CR2","unstructured":"Aktories K, Flockerzi V, F\u00f6rstermann U, Hofmann F, Forth W, Henschler D, Rummel W, Starke K eds. (2022) Allgemeine und spezielle Pharmakologie und Toxikologie: Lehrbuch und Nachschlagewerk f\u00fcr Studierende der Medizin, Zahnmedizin, Pharmazie und Veterin\u00e4rmedizin, f\u00fcr \u00c4rzte, Zahn\u00e4rzte, Apotheker und Tier\u00e4rzte sowie f\u00fcr Wissenschaftlerinnen und Wissenschaftler verwandter Disziplinen. 13. Auflage. (M\u00fcnchen: Elsevier)"},{"key":"3558_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s13181-019-00697-z","volume":"15","author":"AM Arens","year":"2019","unstructured":"Arens AM, Kearney T (2019) Adverse effects of physostigmine. J Med Toxicol 15:184\u2013191. https:\/\/doi.org\/10.1007\/s13181-019-00697-z","journal-title":"J Med Toxicol"},{"key":"3558_CR4","unstructured":"Berufsverband der Augen\u00e4rzte Deutschlands e.V. (2006). Referenzempfehlung der Leitlinie Nr. 15a: Prim\u00e4res chronisches Offenwinkelglaukom Normaldruckglaukom und okul\u00e4re Hypertension Referenzempfehlungen der LL Nr. 15a \u00dcberblick f\u00fcr die Praxis Stand: Oktober 2006. Accessed: 2024, 20 May. https:\/\/www.dog.org\/fuer-aerzte\/leitlinien-stellungnahmen-empfehlungen\/glaukom\/leitlinien-glaukom\/referenzempfehlung-zur-leitlinie-15aprimaeres-chronisches-offenwinkelglaukom-normaldruckglaukom-und-okulaere-hypertension-ueberblick-fuer-die-praxis"},{"key":"3558_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus RT, Dean RL, Beer B, Lippa AS (1982) The Cholinergic Hypothesis of Geriatric Memory Dysfunction. Science 217:408\u2013414. https:\/\/doi.org\/10.1126\/science.7046051","journal-title":"Science"},{"key":"3558_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.37022\/WJCMPR.2020.2207","volume":"02","author":"RN Bongoni","year":"2020","unstructured":"Bongoni RN (2020) Formulation and evaluation of physostigmine-transdermal patch. WJCMPR 02:125\u2013132. https:\/\/doi.org\/10.37022\/WJCMPR.2020.2207","journal-title":"WJCMPR"},{"key":"3558_CR7","first-page":"1","volume-title":"Critical Care Toxicology","author":"WJ Boroughf","year":"2016","unstructured":"Boroughf WJ (2016) Physostigmine. In: Brent J, Burkhart K, Dargan P, Hatten B, Megarbane B, Palmer R (eds) Critical Care Toxicology. Springer International Publishing, Cham, pp 1\u201314"},{"key":"3558_CR8","unstructured":"Brunton LL, Knollmann BC (eds) (2023) Goodman & Gilman\u2019s the pharmacological basis of therapeutics, 14th edn. New York: McGraw Hill"},{"key":"3558_CR9","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"LL Brunton","year":"2006","unstructured":"Brunton LL, Lazo JS, Buxton ILO, Blumenthal DK, Akil H, Amrein PC, Baldessarini RJ, Balser JR, Bennett WM, Bennett JE, Bersot TP, Bickers DR, Bloom FE, Braverman LE, Brown JH, Burke A, Catterall WA, Chabner BA, Chambers HF, Charney DS, Crowder CM, Davis SN, Druker B, Erdos EG, Evers AS et al (2006) Goodman & Gilman\u2019s the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York","edition":"11"},{"key":"3558_CR10","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"LL Brunton","year":"2018","unstructured":"Brunton LL, Knollmann BC, Hilal-Dandan R, contribs. (2018) Goodman & Gilman\u2019s the pharmacological basis of therapeutics, 13th edn. McGraw-Hill Education LLC., New York, N.Y.","edition":"13"},{"key":"3558_CR11","volume-title":"Lehrbuch der Arzneimittellehre","author":"R Buchheim","year":"1878","unstructured":"Buchheim R (1878) Lehrbuch der Arzneimittellehre, 3rd edn. Verlag von Leopald Voss, Leipzig","edition":"3"},{"key":"3558_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001499","author":"JMJ Coelho Filho","year":"2001","unstructured":"Coelho Filho JMJ, Birks J (2001) Physostigmine for dementia due to Alzheimer\u2019s disease. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD001499","journal-title":"Cochrane Database Syst Rev"},{"key":"3558_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/archneur.1974.00490320001001","volume":"30","author":"DA Drachman","year":"1974","unstructured":"Drachman DA, Leavitt J (1974) Human memory and the cholinergic system: a relationship to aging? Arch Neurol 30:113\u2013121","journal-title":"Arch Neurol"},{"key":"3558_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-36488-8","volume-title":"Lehrbuch der Pharmakologie. 3. und","author":"F Eichholtz","year":"1944","unstructured":"Eichholtz F (1944) Lehrbuch der Pharmakologie. 3. und, 4th edn. Springer, Berlin Heidelberg, Berlin, Heidelberg","edition":"4"},{"key":"3558_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-25427-1","volume-title":"Lehrbuch der Pharmakologie im Rahmen einer allgemeinen Krankheitslehre","author":"F Eichholtz","year":"1951","unstructured":"Eichholtz F (1951) Lehrbuch der Pharmakologie im Rahmen einer allgemeinen Krankheitslehre, 7th edn. Springer, Berlin Heidelberg, Berlin, Heidelberg","edition":"7"},{"key":"3558_CR16","unstructured":"Estler,C-J ed. (1986) Lehrbuch der allgemeinen und systematischen Pharmakologie und Toxikologie: f\u00fcr Studierende der Medizin und Naturwissenschaften sowie f\u00fcr \u00c4rzte und Apotheker ; erg\u00e4nzte Studienausgabe\u202f; mit 266 Tabellen und einem Register zum Gegenstandskatalog. Erg. Studienausg. (Stuttgart New York: Schattauer)"},{"key":"3558_CR17","unstructured":"Filehne, W (1901) Dr. A. Cloetta\u2019s Lehrbuch der Arzneimittellehre und Arzneiverordnungslehre. 10., teilweise v\u00f6llig neubearbeitete Auflage. (T\u00fcbingen und Leipzig: Verlag von J.C.B. Mohr (Paul Siebeck))"},{"key":"3558_CR18","volume-title":"Allgemeine und spezielle Pharmakologie und Toxikologie: fuer Studenten d. Medizin, Veterinaermedizin, Pharmazie, Chemie, Biologie sowie fuer Aerzte u. Apotheker. 2, ueberarb. u","year":"1977","unstructured":"Forth W, Henschler D, Rummel W (eds) (1977) Allgemeine und spezielle Pharmakologie und Toxikologie: fuer Studenten d. Medizin, Veterinaermedizin, Pharmazie, Chemie, Biologie sowie fuer Aerzte u. Apotheker. 2, ueberarb. u, erw. Bibliographisches Institut, Mannheim, Wien, Zuerich","edition":"erw"},{"key":"3558_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-58304-3","volume-title":"Pharmakologie und Toxikologie: Von den molekularen Grundlagen zur Pharmakotherapie","author":"M Freissmuth","year":"2020","unstructured":"Freissmuth M, Offermanns S, B\u00f6hm S (2020) Pharmakologie und Toxikologie: Von den molekularen Grundlagen zur Pharmakotherapie, 3rd edn. Springer, Berlin Heidelberg, Berlin, Heidelberg","edition":"3"},{"key":"3558_CR20","unstructured":"Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG eds (1996) Goodman & Gilman\u2019s the pharmacological basis of therapeutics, 9th edn.\u00a0Health Professions Division, New York: McGraw-Hill,\u00a0"},{"key":"3558_CR21","unstructured":"Goodman LS, Gilman A, Gilman AG (eds) (1985) Goodman and Gilman\u2019s the pharmacological basis of therapeutics, 7th edn. New\u00a0York: Macmillan [u.a.]"},{"key":"3558_CR22","volume-title":"Pharmakologie und Toxikologie. 2, vollst\u00e4ndig","author":"K-H Graefe","year":"2016","unstructured":"Graefe K-H, Lutz W, B\u00f6nisch H (2016) Pharmakologie und Toxikologie. 2, vollst\u00e4ndig, \u00fcberarbeitete. Thieme, Stuttgart","edition":"\u00fcberarbeitete"},{"key":"3558_CR23","volume-title":"Theoretische und klinische Pharmakologie","author":"HV Hoesslin","year":"1933","unstructured":"Hoesslin HV, M\u00fcller F (1933) Theoretische und klinische Pharmakologie, 4th edn. Georg Thieme Verlag, Leipzig","edition":"4"},{"key":"3558_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s00740-023-00492-1","volume":"26","author":"T H\u00f6lle","year":"2023","unstructured":"H\u00f6lle T, Purrucker JC, Morath B, Weigand MA, Schmitt FCF (2023) Central anticholinergic, neuroleptic malignant and serotonin syndromes\u202f: important differential diagnoses in postoperative impairment of consciousness. Wien klin Mag 26:124\u2013132. https:\/\/doi.org\/10.1007\/s00740-023-00492-1","journal-title":"Wien klin Mag"},{"key":"3558_CR25","volume-title":"Handbuch der Arzneimittellehre. Mit besonderer Ber\u00fccksichtigung auf die neusten Pharmakop\u00f6en f\u00fcr Studierende und Aerzte","author":"T Husemann","year":"1892","unstructured":"Husemann T (1892) Handbuch der Arzneimittellehre. Mit besonderer Ber\u00fccksichtigung auf die neusten Pharmakop\u00f6en f\u00fcr Studierende und Aerzte, 3rd edn. Verlag von Julius Springer, Berlin","edition":"3"},{"key":"3558_CR26","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s40123-022-00482-2","volume":"11","author":"MA Jackson","year":"2022","unstructured":"Jackson MA, Giyanani J, Shabaik Y, Penzner J, Gore AV, Robinson MR, Waring GO (2022) In vitro and in-eye comparison of commercial pilocarpine ophthalmic solution and an optimized, reformulated pilocarpine for presbyopia treatment. Ophthalmol Ther 11:869\u2013879. https:\/\/doi.org\/10.1007\/s40123-022-00482-2","journal-title":"Ophthalmol Ther"},{"key":"3558_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108303","volume":"182","author":"NK Katz","year":"2021","unstructured":"Katz NK, Barohn RJ (2021) The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis. Neuropharmacology 182:108303","journal-title":"Neuropharmacology"},{"key":"3558_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/diagnostics14010091","volume":"14","author":"A Komuro","year":"2023","unstructured":"Komuro A, Yokoi N, Sotozono C, Kinoshita S (2023) Effectiveness of single-dose oral pilocarpine administration in patients with Sj\u00f6gren\u2019s syndrome. Diagnostics 14:91. https:\/\/doi.org\/10.3390\/diagnostics14010091","journal-title":"Diagnostics"},{"key":"3558_CR29","volume-title":"Kurzes Lehrbuch der Pharmakologie","author":"G Kuschinsky","year":"1964","unstructured":"Kuschinsky G, L\u00fcllmann H (1964) Kurzes Lehrbuch der Pharmakologie, 1st edn. Georg Thieme Verlag, Stuttgart","edition":"1"},{"key":"3558_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03227-z","author":"L Ludwig","year":"2024","unstructured":"Ludwig L, Seifert R (2024) How does pharmacological and toxicological knowledge evolve? A case study on hydrogen cyanide in German pharmacology and toxicology textbooks from 1878 to 2020. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03227-z","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"3558_CR31","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4140\/TCP.n.2018.432","volume":"33","author":"LL Marshall","year":"2018","unstructured":"Marshall LL, Hayslett RL, Stevens GA (2018) Therapy for open-angle glaucoma. Consult Pharm 33:432\u2013445","journal-title":"Consult Pharm"},{"key":"3558_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02877-9","author":"N Misera","year":"2023","unstructured":"Misera N, Seifert R (2023) Presentation of the obsolete drug reserpine in three German-language pharmacology textbooks. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-023-02877-9","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"3558_CR33","volume-title":"Pharmakologie und Toxikologie: mit 144 Tabellen","year":"1997","unstructured":"Oberdisse E, Hackenthal E, Kuschinsky K (eds) (1997) Pharmakologie und Toxikologie: mit 144 Tabellen, 1st edn. Springer, Berlin Heidelberg","edition":"1"},{"key":"3558_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/ICU.0000000000000740","volume":"32","author":"E Ostler","year":"2021","unstructured":"Ostler E, Rhee D, Burney E, Sozeri Y (2021) Advances in medical therapy for glaucoma. Curr Opinion Ophthalmol 32:129\u2013133. https:\/\/doi.org\/10.1097\/ICU.0000000000000740","journal-title":"Curr Opinion Ophthalmol"},{"key":"3558_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1472-6920-14-35","volume":"14","author":"AG Powell","year":"2014","unstructured":"Powell AG, Paterson-Brown S, Drummond GB (2014) Undergraduate medical textbooks do not provide adequate information on intravenous fluid therapy: a systematic survey and suggestions for improvement. BMC Med Educ 14:35. https:\/\/doi.org\/10.1186\/1472-6920-14-35","journal-title":"BMC Med Educ"},{"key":"3558_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/OPX.0b013e3182058ead","volume":"88","author":"T Realini","year":"2011","unstructured":"Realini T (2011) A history of glaucoma pharmacology. Optom Vis Sci 88:36\u201338. https:\/\/doi.org\/10.1097\/OPX.0b013e3182058ead","journal-title":"Optom Vis Sci"},{"key":"3558_CR37","volume-title":"Rang & Dale\u2019s pharmacology","author":"J Ritter","year":"2020","unstructured":"Ritter J, Flower R, Henderson G, Loke YK, MacEwan D, Rang HP (2020) Rang & Dale\u2019s pharmacology, 9th edn. Elsevier, Edinburgh London New York","edition":"9"},{"key":"3558_CR38","volume-title":"Grundriss der Arzneimittellehre","author":"O Schmiedeberg","year":"1883","unstructured":"Schmiedeberg O (1883) Grundriss der Arzneimittellehre, 1st edn. Verlag von F.C.W. Vogel, Leipzig","edition":"1"},{"key":"3558_CR39","volume-title":"Grundriss der Pharmakologie in Bezug auf Arzneimittellehre und Toxikologie","author":"O Schmiedeberg","year":"1921","unstructured":"Schmiedeberg O (1921) Grundriss der Pharmakologie in Bezug auf Arzneimittellehre und Toxikologie, 8th edn. Verlag von F.C.W. Vogel, Leipzig","edition":"8"},{"key":"3558_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-18899-3","volume-title":"Basic Knowledge of Pharmacology","author":"R Seifert","year":"2019","unstructured":"Seifert R (2019) Basic Knowledge of Pharmacology, 1st edn. Springer International Publishing, Cham","edition":"1"},{"key":"3558_CR41","doi-asserted-by":"crossref","unstructured":"Snyder C (1964) Ludwig Laqueur, MD (1839-1909) Arch Ophthalmol 72:111\u2013113","DOI":"10.1001\/archopht.1964.00970020113023"},{"key":"3558_CR42","volume-title":"Lehrbuch der Arzneimittellehre und Arzneiverordnungslehre unter besonderer Ber\u00fccksichtigung der deutschen und \u00f6sterreichischen Pharmakopoe. 13, zum Teil neu","author":"HV Tappeiner","year":"1919","unstructured":"Tappeiner HV (1919) Lehrbuch der Arzneimittellehre und Arzneiverordnungslehre unter besonderer Ber\u00fccksichtigung der deutschen und \u00f6sterreichischen Pharmakopoe. 13, zum Teil neu, bearbeitete. Verlag von F.C.W. Vogel, Leipzig","edition":"bearbeitete"},{"key":"3558_CR43","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archinte.159.2.174","volume":"159","author":"FB Vivino","year":"1999","unstructured":"Vivino FB (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sj\u00f6gren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. Arch Intern Med 159:174. https:\/\/doi.org\/10.1001\/archinte.159.2.174","journal-title":"Arch Intern Med"},{"key":"3558_CR44","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.mayocpiqo.2022.09.007","volume":"6","author":"IV Wagner","year":"2022","unstructured":"Wagner IV, Stewart MW, Dorairaj SK (2022) Updates on the diagnosis and management of glaucoma. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 6:618\u2013635. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2022.09.007","journal-title":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03558-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03558-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03558-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T08:18:33Z","timestamp":1744273113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03558-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3558"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03558-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was carried out in accordance with the guidelines of good scientific practice of Hannover Medical School () and officially registered as a doctoral project for Laureen Ludwig. Hannover Medical School follows the guidelines of the German Research Foundation (DFG).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable, as publicly available information is used as a data source.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"R.S. is the Editor-in-Chief of Naunyn-Schmiedebergs Arch Pharmacol and adheres to the editorial policies regarding editors acting as authors in the journal ().","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}